Legal Representation
Attorney
Laurence R, Hefter
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 20, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 10, 2001 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 21, 2001 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 11, 2001 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 20, 2000 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 4, 2000 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 11, 2000 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 10, 2000 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 18, 2000 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 5, 2000 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Dec 9, 1999 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Nov 18, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceutical for use in treating paraneoplastic and neoplastic diseases and cancer, pharmaceuticals for use as prophylaxis or treatment of infectious diseases, pharmaceuticals for use as adjuvant to vaccination, pharmaceuticals for use in activating or expanding cell populations in ex vivo settings or processes, pharmaceuticals for use in the treatment of immune diseases and immune deficiencies, and pharmaceuticals for use in treatment of bone diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005